-
providing fair access to vaccines and treatments.
At the same time, we want to maintain the levels of protection required for investment in innovation, so we can fight against new strains of COVID-19 and any future disease. The EU does not consider that the broad waiver proposed by a number of WTO members is the right response to the pandemic. We are arguing for a different and more targeted approach.
The EU believes that voluntary licences are the most effective instrument to facilitate expansion of production and share the necessary know-how. There are more than 280 partnerships worldwide which can make the fullest use of these licences.
HONG KONG, June 1 - Vaccines from China are proving critical to Southeast Asian nations as they battle a new wave of COVID-19 infections, experts said, adding that the region can also benefit from China's experience in protecting public health security as well as the economy.
2021-06-03 14:05:42 GMT2021-06-03 22:05:42(Beijing Time) Xinhua English
BEIJING, June 3 (Xinhua) More than 704.8 million doses of COVID-19 vaccines had been administered across China as of Wednesday, the National Health Commission (NHC) said Thursday.
The number of doses administered has continued to rise at an ever-faster rate since China hit the landmark figure of 100 million on March 27.
China took just 25 days to hit the next milestone of administering 200 million doses nationwide. It only took five days to increase vaccine distribution from 600 million doses to 700 million.
A total of 20 vaccines have entered clinical trials in China since last year, according to Zheng Zhongwei, an official with the NHC. China has been taking the lead in terms of the number of vaccines that are being developed.
© Provided by Xinhua BEIJING, June 3 (Xinhua) More than 704.8 million doses of COVID-19 vaccines had been administered across China as of Wednesday,